The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands

Publication Type:
Journal Article


Citation:

Akehurst R, Brereton N, Ariely R, Lusa T, Groot M, Foss P and Boonen S. The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands. J Med Econ. 2011;14(1):53-64.

 


Link to publication ⟶

⟵ Back to Search Results